Confronting Tuberculosis: A Synthetic Quinoline-Isonicotinic Acid Hydrazide Hybrid Compound as a Potent Lead Molecule Against Mycobacterium tuberculosis
Article in ACS Infectious Diseases (May 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Article in ACS Infectious Diseases (May 2024)
Preprint in bioRxiv (May 2024)
Article in Virulence (January 2023)